Skip to content

Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water

SUBstituting With Preferred Options: Health Effects of Substituting Sugar-sweetened Beverages With Non-caloric Beverages in Adults With Overweight and Obesity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04567108
Acronym
SUB-POP
Enrollment
461
Registered
2020-09-28
Start date
2021-04-22
Completion date
2026-05-21
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight

Keywords

Prevention, Weight control, Sugar-sweetened beverages, Artificial sweeteners, Water, Beverages

Brief summary

Sugar-sweetened beverages (SSBs) contribute an alarming \ 7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.

Detailed description

The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool \[subset\]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used. After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs \[all ASB intervention groups combined\] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.

Interventions

BEHAVIORALMaintain usual SSBs

Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)

BEHAVIORALSubstitute to non-SSBs

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

BEHAVIORALStudy app

Engage with a motivational mobile app to track beverage intake and complete study data collection

BEHAVIORALBeverage delivery

Select from approved beverages for a monthly at-home delivery (months 0-6)

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Outcomes assessor will be blinded to participants' beverage assignment at time of outcome assessment; Investigators will be masked to treatment arm assignments during primary analyses

Intervention model description

Parallel randomization on a rolling basis to one of 4 interventions; After 9/1/2023 design is modified to 3 parallel interventions, with sucralose and aspartame interventions combined into one ASB substitution arm

Eligibility

Sex/Gender
ALL
Age
20 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

1. Adults aged 20-69 years 2. Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.) 3. BMI 25.0 to 45.0 kg/m2 4. Access to a smartphone and willingness and ability to download study app 5. Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months

Exclusion criteria

1. Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit 2. Intention to move away from greater Boston area within 1 year from randomization 3. Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.) 4. Phenylketonuria (PKU) 5. Medication that may affect weight or other study endpoints 6. Another family or household member participating in the study 7. Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period

Design outcomes

Primary

MeasureTime frameDescription
Weight Change at 6 monthsBaseline, Month 6Change in total body weight calculated as the month 6 weight minus the baseline weight

Secondary

MeasureTime frameDescription
Waist Circumference ChangeBaseline, Month 6Calculated as month 6 minus baseline value
Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)Baseline, Month 6Calculated as month 6 minus baseline value
Beverage Intake Change (oz/d)Baseline, Month 6Calculated as month 6 minus baseline value
Fasting Plasma Glucose ChangeBaseline, Month 6Calculated as month 6 minus baseline value
Fasting Blood Insulin ChangeBaseline, Month 6Calculated as month 6 minus baseline value
HOMA-IR ChangeBaseline, Month 6Calculated as month 6 minus baseline value
HbA1c ChangeBaseline, Month 6Calculated as month 6 minus baseline value
TG/HDL Ratio ChangeBaseline, Month 6Calculated as month 6 minus baseline value
Weight Change SustainabilityBaseline, Month 6Calculated as month 6 minus baseline value, month 12 minus month 6 value

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDeirdre Tobias, ScD

Brigham and Women's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026